Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
GRADE Study Research Group; Nathan DM, Lachin JM, Bebu I, Burch HB, Buse JB, Cherrington AL, Fortmann SP, Green JB, Kahn SE, Kirkman MS, Krause-Steinrauf H, Larkin ME, Phillips LS, Pop-Busui R, Steffes M, Tiktin M, Tripputi M, Wexler DJ, Younes N.
N Engl J Med. 2022 Sep 22;387(12):1075-1088. doi: 10.1056/NEJMoa2200436.
Type 2 diabetes mellitus.
DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R.
Nat Rev Dis Primers. 2015 Jul 23;1:15019. doi: 10.1038/nrdp.2015.19.
Cardiac Autonomic Neuropathy in Diabetes Mellitus.
Agashe S, Petak S.
Methodist Debakey Cardiovasc J. 2018 Oct-Dec;14(4):251-256. doi: 10.14797/mdcj-14-4-251.
Approach to the Patient with MODY-Monogenic Diabetes.
Broome DT, Pantalone KM, Kashyap SR, Philipson LH.
J Clin Endocrinol Metab. 2021 Jan 1;106(1):237-250. doi: 10.1210/clinem/dgaa710.
Genetics of diabetes-associated microvascular complications.
Lyssenko V, Vaag A.
Diabetologia. 2023 Sep;66(9):1601-1613. doi: 10.1007/s00125-023-05964-x. Epub 2023 Jul 14.
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes.
Hicks CW, Selvin E.
Curr Diab Rep. 2019 Aug 27;19(10):86. doi: 10.1007/s11892-019-1212-8.
Diabetic microvascular complications are associated with left atrial structural alterations in asymptomatic type 2 diabetes patients: A cross-sectional study.
Gong M, Xu M, Meng J, Jiang S, Jiang X.
J Diabetes Complications. 2023 Jan;37(1):108361. doi: 10.1016/j.jdiacomp.2022.108361. Epub 2022 Nov 30.
Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications.
Xiong J, Hu H, Guo R, Wang H, Jiang H.
Front Endocrinol (Lausanne). 2021 Apr 29;12:646233. doi: 10.3389/fendo.2021.646233. eCollection 2021.
A plant-based diet for the prevention and treatment of type 2 diabetes.
McMacken M, Shah S.
J Geriatr Cardiol. 2017 May;14(5):342-354. doi: 10.11909/j.issn.1671-5411.2017.05.009.
Glucagon-like peptide 1 receptor agonists in type 1 diabetes mellitus.
Guyton J, Jeon M, Brooks A.
Am J Health Syst Pharm. 2019 Oct 15;76(21):1739-1748. doi: 10.1093/ajhp/zxz179.
